85323-4
LaboratoryResponse to neoadjuvant therapy in Breast cancer specimen Qualitative
Definition
The response of the tumor to neoadjuvant treatment, such as chemotherapy or endocrine therapy. The response of invasive breast carcinoma to neoadjuvant therapy is associated with increased disease-free and overall survival.
LOINC 6-Axis Classification
Component
Response to neoadjuvant therapy
Property
Find
Time Aspect
Pt
System
Breast cancer specimen
Scale Type
Ord
Method Type
N/A
Details
Class
PATH
Order/Observation
Observation
Short Name
Resp to neoadjvt therapy Br ca spec Ql
Display Name
Response to neoadjuvant therapy Ql (Breast cancer specimen)
Related Names
Frequently Asked Questions
What is LOINC code 85323-4?
LOINC code 85323-4 identifies "Response to neoadjuvant therapy in Breast cancer specimen Qualitative". The response of the tumor to neoadjuvant treatment, such as chemotherapy or endocrine therapy. The response of invasive breast carcinoma to neoadjuvant therapy is associated with increased disease-free and overall survival.
What does 85323-4 measure?
This code measures Response to neoadjuvant therapy in Breast cancer specimen. It belongs to the PATH class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.